How many clinical trials are studying Psilocybin 25 mg?

3 recruiting trials in our tracked data involve Psilocybin 25 mg.

What conditions is Psilocybin 25 mg being studied for?

In our tracked recruiting trials, Psilocybin 25 mg is being studied in trials for Depression, Treatment Resistant Depression, Bipolar II Depression.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 2 3

Condition	Trials
Depression	2
Treatment Resistant Depression	2
Bipolar II Depression	1
Bipolar disorder	1
Chronic Pain	1

Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)
NCT06512220 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder
NCT06943573 · Phase: Phase 2 · Ages: 19 Years to 65 Years · Sex: All (male and female) · 3 locations
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)
NCT06518720 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location